1. |
Folkman J. Tumor angiogenesis: therapeutic implications [J]. N Engl J Med, 1971; 285(21)∶1182.
|
2. |
Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis [J]. Cell, 1996; 87(7)∶1171.
|
3. |
Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [J]. Science, 1997; 277(5322)∶55.
|
4. |
Sato TN, Qin Y, Kozak CA, et al. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system [J]. Proc Natl Acad Sci USA, 1993; 90(20)∶9355.
|
5. |
Fiedler U, Krissl T, Koidl S, et al. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats [J]. J Biol Chem, 2003; 278(3)∶1721.
|
6. |
Sato TN, Tozawa Y, Deutsch U, et al.Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation [J]. Nature, 1995; 376(6535)∶70.
|
7. |
孙秀菊, 付浩, 郑志红, 等. Ang2基因表达与胃癌发生发展的关系 [J]. 中国肿瘤临床, 2003; 30(8)∶536.
|
8. |
Etoh T, Inoue H, Tanaka S, et al. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases [J]. Cancer Res, 2001; 61(5)∶2145.
|
9. |
张宁, 陶凯雄, 王国斌, 等. 环氧合酶-2及血管生成素-2在大肠癌中的表达及临床意义 [J]. 中国普外基础与临床杂志, 2006; 13(5)∶564.
|
10. |
Du JR, Jiang Y, Zhang YM, et al. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas [J]. World J Gastroenterol, 2003; 9(7)∶1604.
|
11. |
Kim I, Kim HG, So JN, et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’Kinase/Akt signal transduction pathway [J].Circ Res, 2000; 86(1)∶24.
|
12. |
Fujikawa K, de Aos Scherpenseel I, Jain SK, et al. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells [J]. Exp Cell Res, 1999; 253(2)∶663.
|
13. |
Papapetropoulos A, Fulton D, Mahboubi K, et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway [J]. J Biol Chem, 2000; 275(13)∶9102.
|
14. |
DeBusk LM, Hallahan DE, Lin PC. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway [J].Exp Cell Res, 2004; 298(1)∶167.
|
15. |
Lin P, Buxton JA, Acheson A, et al. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2 [J]. Proc Natl Acad Sci USA, 1998; 95(15)∶8829.
|
16. |
Siemeister G, Schirner M, Weindel K, et al. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway [J]. Cancer Res, 1999; 59(13)∶3185.
|
17. |
罗彦, 文艳君, 田聆, 等. 鸡tie-2受体胞外片段重组蛋白的制备及其抗血管生成作用的研究 [J]. 中华医学遗传学杂志, 2004; 21(2)∶101.
|
18. |
罗彦, 田聆, 吴扬, 等. 鸡Tie-2受体胞外片段的原核表达及目的蛋白免疫原性的研究 [J]. 四川大学学报(医学版), 2004; 35(2)∶154.
|
19. |
王天宝, 李兆亭. 血管内皮生长因子及微血管密度与胃癌进展的关系 [J]. 中国普外基础与临床杂志, 2002; 9(3)∶159.
|